FDA approves updated Covid-19 vaccines for dominant XFG variant
Summary
The US Food and Drug Administration (FDA) approved updated Covid-19 vaccines targeting the dominant XFG variant. These vaccines from Moderna, Novavax-Sanofi, and Pfizer-BioNTech can now be distributed to people at higher risk, mainly those 65 and older or younger individuals with certain health conditions.Key Facts
- The FDA approved updated Covid vaccines to target the XFG variant.
- Moderna, Novavax-Sanofi, and Pfizer-BioNTech are the manufacturers of the updated vaccines.
- Vaccines are for people 65 and older, and younger people with health conditions that increase Covid risk.
- Age approvals vary: Moderna for children 6 months and older, Pfizer-BioNTech for age 5 and older, Novavax-Sanofi for age 12 and older.
- The Trump administration changed vaccine recommendations last fall, advising vaccinations based on personal choice.
- The CDC’s vaccine advisory panel is currently inactive, causing uncertainty about future vaccine recommendations.
- It is unclear if health insurers will cover the updated vaccines without CDC panel recommendations.
- Covid-19 activity in the US is currently low but has been increasing slightly in recent weeks.
Read the Full Article
This is a fact-based summary from The Actual News. Click below to read the complete story directly from the original source.
